Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies

Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients

A bispecific antibody talquetamab shows promising efficacy in relapsed/refractory multiple myeloma

Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients

The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma

Quizartinib improves overall survival in adult patients with FLT3-ITD+ acute myeloid leukaemia

Adagrasib shows CNS penetration and encouraging intracranial activity for KRASG12C-mutated NSCLC and active, untreated CNS metastases